Join us   Log in  

PHARMASPIRE - Volume 12, Issue 4, October- December, 2020

Pages: 139-144

Date of Publication: 10-Jun-2022

Print Article   Download XML  Download PDF

Anxiety: An overview

Author: Gursharan Kaur, Gurmeet Singh, Amandeep Singh

Category: Pharmaceutics


Anxiety is debatably a feeling that originates before the advancement of man. Its universality in people, and its quality in a scope of anxiety issues, makes it a significant clinical core interest. There are numerous reasons for it such as hereditary factor, substance utilized, and some more. There is proof that nervousness can be treated with physical therapy and additionally with drugs. First-line pharmacotherapies are particular serotonin reuptake inhibitors (Selective serotonin reuptake inhibitors [SSRIs]), serotoninnorepinephrine reuptake inhibitors (SNRIs). In the event that such treatments fizzle, one may rethink the finding, question adherence with the recommended plan, and decide the antagonistic impact of comorbidity, (e.g., misery, substance use, and actual weakness) just as the impact of social stressors. Second-line pharmacotherapies are generally not upheld by controlled preliminaries, thus leave a lot to clinical judgment and cautious observing. One may endeavor medicines with benzodiazepine anxiolytics, as a subordinate treatment in patients with fractional reaction to SSRI or SNRI treatment. Meditation and exercise are substantial option to pharmacotherapy, depending on patient preference.

Keywords: Anxiety, selective serotonin reuptake inhibitor, serotonin-norepinephrine reuptake inhibitors


1. Herring MP, Jacob ML, Suveg C, O’Connor PJ. Effects of short-term exercise training on signs and symptoms of generalized anxiety disorder. Ment Health Phys Act 2011;4:71-7.

2. Reid M, Wilson-Walsh R, Cartwright L, Hammersley R. Stuffing down feelings: Bereavement, anxiety and emotional detachment in the life stories of people with eating disorders. Health Soc Care Community 2020;28:979-87.

3. Muris P. Relationships between self-efficacy and symptoms of anxiety disorders and depression in a normal adolescent sample. Pers Individ Dif 2002;32:337-48.

4. Silverman WK, Nelles WB. The anxiety disorders interview schedule for children. J Am Acad Child Adolesc Psychiatry 1988;27:772-8.

5. Anderson EH, Shivakumar G. Effects of exercise and physical activity on anxiety. Front Psychiatry 2013;4:27.

6. Archer J, Bower P, Gilbody S, Lovell K, Richards D, Gask L, et al. Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev 2012;10:CD006525.

7. Lakhan SE, Vieira KF. Nutritional and herbal supplements for anxiety and anxiety-related disorders: Systematic review. Nutr J 2010;9:42.

8. Kehoe WA. Generalized Anxiety Disorder. Bethesda, MD: Ambulatory Care Pharmacy Self-Assessment Program; 2017. p. 1-21.

9. Singh D, Alok S, Mahor A, Kumar K. A review: Medicinal plants with antidepressant properties. World J Pharm Pharm Sci 2020;6:1-5.

10. Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci 2017;19:93-107.

11. Locke A, Kirst N, Shultz CG. Diagnosis and management of generalized anxiety disorder and panic disorder in adults. Am Fam Physician 2015;91:617-24.

12. Fineberg NA, Haddad PM, Carpenter L, Gannon B, Sharpe R, Young AH, et al. The size, burden and cost of disorders of the brain in the UK. J Psychopharmacol 2013;27:761-70.

13. Bryan ML. Job-Related Stress, Working Time and Work Schedules. Vol. 1. Kolkata: Indian Institutes of Science Education and Research; 2017. p. 5-15.

14. Baumeister SE, Leitzmann MF, Bahls M, Dörr M, Schmid D, Schomerus G, et al. Associations of leisure-time and occupational physical activity and cardiorespiratory fitness with incident and recurrent major depressive disorder, depressive symptoms, and incident anxiety in a general population. J Clin Psychiatry 2017;78:e41-7.

15. Kandola A, Vancampfort D, Herring M, Rebar A, Hallgren M, Firth J, et al. Moving to beat anxiety: Epidemiology and therapeutic issues with physical activity for anxiety. Curr Psychiatry Rep 2018;20:63.

16. Wu X, Tao S, Zhang Y, Zhang S, Tao F. Low physical activity and high screen time can increase the risks of mental health problems and poor sleep quality among Chinese college students. PLoS One 2015;10:e0119607.

17. Fenger M, Lindschou J, Gluud C, Winkel P, Jørgensen L, Dybkjaer JH, et al. Internet-based therapy with FearFighter for anxiety disorders: A randomised clinical trial. Nord J Psychiatry 2020;74:518-24.

18. Pull CB. Self-help internet interventions for mental disorders. Curr Opin Psychiatry 2006;19:50-3.

19. Craske MG, Rauch SL, Ursano R, Prenoveau J, Pine DS, Zinbarg RE. What is an anxiety disorder? Focus 2011;9:369-88.

20. Dugas MJ, Gagnon F, Ladouceur R, Freeston MH. Generalized anxiety disorder: A preliminary test of a conceptual model. Behav Res Ther 1998;36:215-26.

21. Rowa K, Antony MM. Generalized Anxiety Disorder. 22. Wittchen HU, Hoyer J. Generalized anxiety disorder: Nature and course. J Clin Psychiatry 2001;62:15-21.

23. Tyrer P, Baldwin D. Generalised anxiety disorder. Lancet 2006;368:2156-66.

24. Blazer DA, Hughes D, George LK, Swartz M, Boyer R. The diagnosis of generalized anxiety disorder. In: Psychiatric Disorders in America: How to Take Immediate Control of Your Mental, Emotional, Physical and Financial; 1991. p. 180.